Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Name: Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Published: 2017
License: Public Domain

National Cancer Institute (NCI) · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

metastatic fallopian tube carcinoma, metastatic ovarian carcinoma, metastatic primary peritoneal carcinoma, ovarian endometrioid tumor, ovarian high grade serous adenocarcinoma, platinum-sensitive ovarian carcinoma, recurrent fallopian tube carcinoma, recurrent ovarian carcinoma, recurrent primary peritoneal carcinoma, stage iv fallopian tube cancer ajcc v6 and v7, stage iv ovarian cancer ajcc v6 and v7, stage iv primary peritoneal cancer ajcc v7

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 826940
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.